![]() They also incorporate multiple herbal and nutritional supplements to slowly bring the body's hormones back into balance thus stopping the growth of fibroids. Most alternative, natural approaches to treating fibroids focus on radical diet and lifestyle changes. Two to six months is the common report for the duration of Systemic Enzyme Therapy. Most women realize a reduction in the size of their fibroids by the first eight weeks. Specific enzymes such as serrapeptase are responsible for the digestion and shrinking of fibroid tumors. Fibrin is the material of fibroids and all scar tissue. Systemic enzyme formulas can be highly fibrinolytic, meaning that they dissolve fibrin. They reduce systemic inflammation, dissolve arterial plaque, cleanse the blood and improve circulation. ![]() They are taken in divided doses between meals so that the protein eating enzymes (proteolytic enzymes) are not expended with the task of digesting food and can enter the bloodstream where they travel to every area of the body, seeking and dissolving old proteins, parasites, bacteria, viruses and dead cells. As the name implies, these enzyme formulas are designed to work throughout the body's system. While many are familiar with taking digestive enzymes at mealtime to improve digestion, systemic enzymes have a different focus. have fibroid tumors, I hope to raise awareness of Systemic Enzyme Therapy so that women who have to seek treatment are empowered with more choices. Since it is estimated that the majority of women in the U.S. Systemic Enzyme Therapy is one of the least known natural treatment approaches to fibrotic disease. These results must be confirmed in other populations, and consider additional genes and variants within the estrogen metabolism pathway.Are you curious about the claims being made about dissolving uterine fibroids with an enzyme supplement? Having an understanding of how enzymes work and how to use them is critical to finding success with this easy, natural approach. Our results reveal possible relationships between CYP1A1*3 and *4 polymorphisms and fibroid prevalence. Analyses of effect measure modification by age, body mass index, smoking status, alcohol use, oral contraceptive use, and number of fullterm births did not show deviations from additive or multiplicative expectations. Estimates for CYP1B1 and COMT alleles were close to the null. Haplotypes and diplotypes that included CYP1A1*3 and CYP1A1*4 showed similar results. African Americans were more likely to have fibroids (72% vs 50%) and to have large fibroids (24% vs 11%) than Whites. Haplotypes and diplotypes were inferred for CYP1A1 and CYP1B1. Race-specific prevalence ratios (PR) and 95% confidence intervals (CI) were estimated from log-risk regression models prevalence differences (PD) and 95% CI were estimated from linear-risk regression models. Participants provided DNA samples and completed telephone interviews and questionnaires. Four single nucleotide polymorphisms (SNP) of CYP1A1, 2 SNPs of CYP1B1, and 1 SNP of COMT were evaluated for associations with fibroid prevalence and size in a cross-sectional sample of premenopausal African American (n=583) and White (n=404) women from the National Institute of Environmental Health Sciences Uterine Fibroid Study. Cytochrome P-450 1A1 (CYP1A1), Cytochrome P-450 1B1 (CYP1B1), and Catechol-O-Methyltransferase (COMT) are polymorphic genes that encode key enzymes in the estrogen metabolism pathway. ![]() The biologic effect of estrogen is influenced by estrogen metabolism therefore estrogen metabolism enzymes may influence fibroid development. Although benign, the etiology of fibroids is largely unknown, however they are hormonally dependent. They occur more often and are larger in African American women compared to White women.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |